Clinica Ortopedica e Traumatologica 2, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Am J Sports Med. 2024 Jul;52(8):1997-2007. doi: 10.1177/03635465241253849. Epub 2024 Jun 10.
Meniscal allograft transplantation (MAT) is a viable option for patients experiencing unicompartmental knee pain after total or subtotal meniscectomy. Nonetheless, caution is recommended when suggesting this procedure in the presence of knee osteoarthritis (OA) because of the higher risk of poor survival and outcomes.
PURPOSE/HYPOTHESIS: The purpose was to document the long-term survival of MAT performed as a salvage procedure in patients with knee OA. The hypothesis was that MAT would significantly reduce pain and increase the function of the affected joint at a long-term follow-up compared with the preoperative condition, with a low number of failures and knee replacement surgeries.
Case series; Level of evidence, 4.
A total of 47 patients (37 men and 10 women) with symptomatic knee OA (Kellgren-Lawrence grades 2 or 3) treated with MAT were evaluated at baseline, 5 years, and a minimum 10-year final follow-up (11.1 ± 1 years) using the Lysholm score, the visual analog scale for pain, the Knee injury and Osteoarthritis Outcome Score subscales, and the Tegner score. A total of 44 patients had undergone previous surgeries. Patient satisfaction, revision surgeries, and failures were also recorded.
A statistically significant improvement was observed in all clinical scores from the baseline assessment to the final follow-up. The Lysholm score improved significantly from 46.4 ± 17.2 at the preoperative assessment to 77.7 ± 20.4 at the intermediate follow-up ( < .001), with a significant decrease at the final follow-up (71 ± 23.3; = .018). A similar trend was reported for the visual analog scale scale for pain, Knee injury and Osteoarthritis Outcome Score, and Tegner score, with no complete recovery to the previous sports activity level. A total of 33 patients required concurrent procedures, such as anterior cruciate ligament reconstructions, osteotomies, and cartilage procedures. Five patients underwent reoperation and were considered surgical failures, while 15 patients presented a clinical condition of <65 of the Lysholm score and were considered clinical failures. Among these, 4 patients were considered both surgical and clinical failures.
MAT surgery has proven to be a valid option for improving pain and function even in OA joints (Kellgren-Lawrence grades 2 or 3), yielding satisfactory results despite a worsening clinical outcome in the long-term follow-up. Therefore, based on the data from this study, orthopaedic surgeons may consider recommending MAT as a salvage procedure even in knees affected by early to moderate OA, while advising patients that the need for combined interventions could potentially reduce graft survival.
半月板同种异体移植(MAT)是全膝关节或次全膝关节半月板切除术后出现单室膝关节疼痛患者的可行选择。然而,由于存在较高的存活率和结果不佳的风险,在膝关节骨关节炎(OA)存在的情况下,建议谨慎使用这种方法。
目的/假设:本研究旨在记录 MAT 作为膝关节 OA 患者挽救性手术的长期存活率。假设与术前相比,MAT 会显著减轻疼痛并增加受影响关节的功能,并且失败和膝关节置换手术的数量较少。
病例系列;证据水平,4 级。
共有 47 名(37 名男性和 10 名女性)有症状的膝关节 OA(Kellgren-Lawrence 分级 2 或 3)患者接受 MAT 治疗,在基线、5 年和至少 10 年的最终随访(11.1 ± 1 年)时使用 Lysholm 评分、疼痛视觉模拟评分、膝关节损伤和骨关节炎结果评分亚量表以及 Tegner 评分进行评估。共有 44 名患者接受了以前的手术。还记录了患者满意度、翻修手术和失败情况。
所有临床评分均从基线评估到最终随访均有统计学显著改善。Lysholm 评分从术前评估的 46.4 ± 17.2 显著改善到中期随访的 77.7 ± 20.4(<.001),最终随访时显著下降(71 ± 23.3;=.018)。疼痛视觉模拟评分、膝关节损伤和骨关节炎结果评分以及 Tegner 评分也报告了类似的趋势,且无完全恢复到以前的运动活动水平。共有 33 名患者需要同时进行手术,如前交叉韧带重建、截骨术和软骨手术。5 名患者需要再次手术,被认为是手术失败,而 15 名患者的 Lysholm 评分为<65,被认为是临床失败。其中,4 名患者同时存在手术和临床失败。
MAT 手术已被证明是一种有效的改善疼痛和功能的选择,即使在 OA 关节(Kellgren-Lawrence 分级 2 或 3)中也是如此,尽管在长期随访中临床结果恶化,但仍能获得满意的结果。因此,根据本研究的数据,矫形外科医生可能会考虑即使在受早期至中期 OA 影响的膝关节中,也将 MAT 推荐为挽救性手术,同时告知患者,联合干预的需求可能会降低移植物的存活率。